Cargando…
Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?
Mucopolysaccharidoses (MPSs) are a group of lysosomal storage disorders (LSDs). The increasing interest in newborn screening procedures for LSDs underlines the need for alternative cellular and gene therapy approaches to be developed during the perinatal period, supporting the treatment of MPS patie...
Autores principales: | Tomatsu, Shunji, Azario, Isabella, Sawamoto, Kazuki, Pievani, Alice Silvia, Biondi, Andrea, Serafini, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754332/ https://www.ncbi.nlm.nih.gov/pubmed/26578156 http://dx.doi.org/10.1007/s10545-015-9900-2 |
Ejemplares similares
-
Evading the AAV Immune Response in Mucopolysaccharidoses
por: Piechnik, Matthew, et al.
Publicado: (2020) -
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I
por: Azario, Isabella, et al.
Publicado: (2017) -
Epidemiology of Mucopolysaccharidoses Update
por: Celik, Betul, et al.
Publicado: (2021) -
Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets
por: Leal, Andrés Felipe, et al.
Publicado: (2022) -
Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model
por: Sawamoto, Kazuki, et al.
Publicado: (2019)